Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) EBT Margin (2016 - 2026)

OptimizeRx's EBT Margin history spans 16 years, with the latest figure at 23.17% for Q4 2025.

  • On a quarterly basis, EBT Margin rose 1634.0% to 23.17% in Q4 2025 year-over-year; TTM through Dec 2025 was 6.35%, a 2739.0% increase, with the full-year FY2025 number at 6.35%, up 2739.0% from a year prior.
  • EBT Margin hit 23.17% in Q4 2025 for OptimizeRx, up from 4.02% in the prior quarter.
  • Over the last five years, EBT Margin for OPRX hit a ceiling of 23.17% in Q4 2025 and a floor of 49.2% in Q1 2023.
  • Historically, EBT Margin has averaged 14.99% across 5 years, with a median of 16.26% in 2023.
  • Biggest five-year swings in EBT Margin: tumbled -3973bps in 2023 and later soared 5068bps in 2025.
  • Tracing OPRX's EBT Margin over 5 years: stood at 3.07% in 2021, then crashed by -154bps to 1.66% in 2022, then tumbled by -2396bps to 41.38% in 2023, then soared by 117bps to 6.83% in 2024, then soared by 239bps to 23.17% in 2025.
  • Business Quant data shows EBT Margin for OPRX at 23.17% in Q4 2025, 4.02% in Q3 2025, and 5.87% in Q2 2025.